HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Estra-1,3,5(10)-trien-3,17β-diol-17-(cyclopentanpropionat)
ESTRADIOL CYPIONATE · DEPOFEMIN · Estrofem · Estradial Cypionate · β-Estradiol 17-cypionate · Estradiol cyclopentylpropionate · (17b)-estra-1,3,5(10)-triene-3,17-diol17-cyclopentanepropanoate · 3-cyclopentylpropanoic acid [(13S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

Identifikatoren & physikalische Daten
| CAS No. | 313-06-4 |
|---|---|
| Summenformel | C26H36O3 |
| Durchschnittliche Molmasse | 396,6 g/mol |
| Monoisotopische Masse | 396,26644501 g/mol |
| SMILES | C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1 |
| InChIKey | UOACKFBJUYNSLK-XRKIENNPSA-N |
| PubChem CID | 9403 |
| ChEMBL | CHEMBL1200973 |
| ChEBI | CHEBI:34745 |
| EC No. | 206-237-8 |
| DTXSID | DTXSID4022999 |
| Lokaler Name | Estra-1,3,5(10)-trien-3,17β-diol-17-(cyclopentanpropionat) |
Chemische & physikalische Eigenschaften
| XLogP | 7,1 |
|---|---|
| Polarare Oberfläche (TPSA) | 46,5 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 5 |
| Schwere Atome | 29 |
| Formalladung | 0 |
| Komplexität | 597 |
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
| Human Drugs | Breast FeedingLactationMilk, HumanEstrogensHormonesFDA approved drugs -> Active ingredientPharmaceuticals |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Collision Cross Section | 220.4 Ų [M-H]- [CCS Type: DTBuffer gas: N2Ionization: ESI-Dataset: TOXCASTSource Identifier: DTXSID4022999] |
| Schmelzpunkt | 151-152° |
| Siedepunkt | 460.24°C (rough estimate) |
| Dichte | 1.0828 (rough estimate) |
| Brechungsindex | 1.4700 (estimate) |
| Lagerbedingungen | Refrigerator |
| Löslichkeit | Chloroform (Slightly), Methanol (Slightly) |
| pKa (Säurekonstante) | 10.25±0.60(Predicted) |
| Aggregatzustand | Solid |
| Farbe | White to Off-White |
| Biologische Quelle | synthetic (organic) |
| InChIKey | UOACKFBJUYNSLK-JCRQLOERNA-N |
| SMILES | C[C@]12CC[C@]3([H])C4C=CC(O)=CC=4CC[C@@]3([H])[C@]1([H])CC[C@@H]2OC(=O)CCC1CCCC1 |&1:1,4,15,17,21,r| |
| CAS Datenbank | 313-06-4(CAS DataBase Reference) |
| NIST chemische Informationen | Estradiol cypionate(313-06-4) |
| EPA chemische Informationen | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate (313-06-4) |
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH302 (95.1%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Regulatorische Informationen | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right. |
| Weitere Sicherheitsinformationen | IMAP assessments - Estra-1,3,5(10)-triene-3,17-diol, 17-cyclopentanepropanoate, (17.beta.)-: Environment tier I assessment |
| Hazard Classes and Categories | Acute Tox. 4 (95.1%) |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| Wassergefährdungsklasse (WGK) | 3 |
| TSCA-Inventar-Status | TSCA listed |
| Zollcode | 29372390 |
| RTECS-Nr. | KG4600000 |
| R-Sätze (R) | 45-46-61-20/21/22-36/37/38 |
| Gefahrensymbole | T,Xi |
| Sicherheitshinweise (S) | 53-22-36/37/39-45-26 |
| Lagerklasse | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
| Gefahrenklasse | Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralCarc. 1BRepr. 1B |
Anwendungen & Verwendung
Verwenden
Estradiol Cypionate is the cypionate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol Cypionate is present in injectable contraceptive formulations. Used in hormone replacement therapy with potential for improving cognition in post-menopausal women.